These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26615088)

  • 1. Retrospective survey to evaluate the safety and efficacy of Japanese botulinum antitoxin therapy in Japan.
    Mottate K; Yokote H; Mori S; Horita A; Miyatsu Y; Torii Y; Kozaki S; Iwaki M; Takahashi M; Ginnaga A
    Toxicon; 2016 Feb; 110():12-8. PubMed ID: 26615088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Workgroup Report by the Joint Task Force Involving American Academy of Allergy, Asthma & Immunology (AAAAI); Food Allergy, Anaphylaxis, Dermatology and Drug Allergy (FADDA) (Adverse Reactions to Foods Committee and Adverse Reactions to Drugs, Biologicals, and Latex Committee); and the Centers for Disease Control and Prevention Botulism Clinical Treatment Guidelines Workgroup-Allergic Reactions to Botulinum Antitoxin: A Systematic Review.
    Schussler E; Sobel J; Hsu J; Yu P; Meaney-Delman D; Grammer LC; Nowak-Wegrzyn A
    Clin Infect Dis; 2017 Dec; 66(suppl_1):S65-S72. PubMed ID: 29293931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Improved Clinical Outcomes in Patients Treated With New Equine-Derived Heptavalent Botulinum Antitoxin.
    Yu PA; Lin NH; Mahon BE; Sobel J; Yu Y; Mody RK; Gu W; Clements J; Kim HJ; Rao AK
    Clin Infect Dis; 2017 Dec; 66(suppl_1):S57-S64. PubMed ID: 29293928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization of the Japanese National Standard, Equine Botulinum Antitoxin Type A, and Factors Affecting Standardization.
    Yutani M; Senoh M; Yano H; Kenri T; Iwaki M
    Jpn J Infect Dis; 2024 Jan; 77(1):16-20. PubMed ID: 37648491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed Antitoxin Treatment of Two Adult Patients with Botulism after Cosmetic Injection of Botulinum Type A Toxin.
    Fan KL; Wang YL; Chu G; Leung LP
    J Emerg Med; 2016 Dec; 51(6):677-679. PubMed ID: 27687174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric Botulism and Use of Equine Botulinum Antitoxin in Children: A Systematic Review.
    Griese SE; Kisselburgh HM; Bartenfeld MT; Thomas E; Rao AK; Sobel J; Dziuban EJ
    Clin Infect Dis; 2017 Dec; 66(suppl_1):S17-S29. PubMed ID: 29293924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iatrogenic Botulism: A Case Treated With Botulinum Antitoxin.
    Gonul Oner O; Gudek HC; Erturk Cetin O; Demir S
    Clin Neuropharmacol; 2023 Mar-Apr 01; 46(2):82-84. PubMed ID: 36728838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Question 1: In infant botulism, is equine-derived botulinum antitoxin (EqBA) an effective alternative therapy to human-derived botulinum immune globulin (BIG)?
    Moneim J
    Arch Dis Child; 2018 Sep; 103(9):907-909. PubMed ID: 30007943
    [No Abstract]   [Full Text] [Related]  

  • 9. Foodborne botulism treated with heptavalent botulism antitoxin.
    Hill SE; Iqbal R; Cadiz CL; Le J
    Ann Pharmacother; 2013 Feb; 47(2):e12. PubMed ID: 23362041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulism in Spain: Epidemiology and Outcomes of Antitoxin Treatment, 1997-2019.
    Peñuelas M; Guerrero-Vadillo M; Valdezate S; Zamora MJ; Leon-Gomez I; Flores-Cuéllar Á; Carrasco G; Díaz-García O; Varela C
    Toxins (Basel); 2022 Dec; 15(1):. PubMed ID: 36668823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product.
    Anderson DM; Kumar VR; Arper DL; Kruger E; Bilir SP; Richardson JS
    PLoS One; 2019; 14(11):e0224700. PubMed ID: 31697731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Antitoxin Therapy in Treating Patients With Foodborne Botulism: A Systematic Review and Meta-analysis of Cases, 1923-2016.
    O'Horo JC; Harper EP; El Rafei A; Ali R; DeSimone DC; Sakusic A; Abu Saleh OM; Marcelin JR; Tan EM; Rao AK; Sobel J; Tosh PK
    Clin Infect Dis; 2017 Dec; 66(suppl_1):S43-S56. PubMed ID: 29293927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current trends in botulism in the United States.
    Merson MH; Hughes JM; Dowell VR; Taylor A; Barker WH; Gangarosa EJ
    JAMA; 1974 Sep; 229(10):1305-8. PubMed ID: 4604287
    [No Abstract]   [Full Text] [Related]  

  • 14. Early antitoxin treatment in wound botulism results in better outcome.
    Chang GY; Ganguly G
    Eur Neurol; 2003; 49(3):151-3. PubMed ID: 12646758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques.
    Kodihalli S; Emanuel A; Takla T; Hua Y; Hobbs C; LeClaire R; O'Donnell DC
    PLoS One; 2017; 12(11):e0186892. PubMed ID: 29166654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Rabbit Spirometry Model of Type E Botulism and Its Use for the Evaluation of Postsymptom Antitoxin Efficacy.
    Diamant E; Pass A; Rosen O; Ben David A; Torgeman A; Barnea A; Tal A; Rosner A; Zichel R
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equine antitoxin use and other factors that predict outcome in type A foodborne botulism.
    Tacket CO; Shandera WX; Mann JM; Hargrett NT; Blake PA
    Am J Med; 1984 May; 76(5):794-8. PubMed ID: 6720725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective study of 108 cases of botulism in Poitiers, France.
    Roblot P; Roblot F; Fauchère JL; Devilleger A; Maréchaud R; Breux JP; Grollier G; Becq-Giraudon B
    J Med Microbiol; 1994 Jun; 40(6):379-84. PubMed ID: 8006928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Botulism antitoxin treatment in two cases of foodborne botulism].
    Tejada García M; Guindel Jiménez C
    Farm Hosp; 2010; 34(1):47-8. PubMed ID: 20144823
    [No Abstract]   [Full Text] [Related]  

  • 20. Equine botulinum antitoxin for the treatment of infant botulism.
    Vanella de Cuetos EE; Fernandez RA; Bianco MI; Sartori OJ; Piovano ML; Lúquez C; de Jong LI
    Clin Vaccine Immunol; 2011 Nov; 18(11):1845-9. PubMed ID: 21918119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.